Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2197
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAdebisi, S.A-
dc.contributor.authorOluboyo, P.O-
dc.contributor.authorOkesina, A.B-
dc.date.accessioned2024-07-18T09:19:59Z-
dc.date.available2024-07-18T09:19:59Z-
dc.date.issued2000-
dc.identifier.citationAfr J. Med med. Sci. (2000) 29, 297 300en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/2197-
dc.descriptionArticleen_US
dc.description.abstractome anti-tuberculosis chemotherapeutic agents have been established as causing hyperuricaemia. Hyperuricaemia in turn causes renal damage. This study therefore aims at establishing the effect of anti-tuberculosis drugs-induced hyperuricaemia on renal function of the patients. Fifty patients with newly diagnosed pulmonary tuberculosis with mean age of 36.8 years (SD 13.69) consisting of 14 females and 17 males were longitudinally studied each for 6 months to determine the effect of drug-induced hyperuricaemia on their renal function. The Biochemical indices determined included serum urate level, serum creatinine level, and creatinine clearance of newly diagnosed patient with tuberculosis, before and during treatment with anti-tuberculosis therapy. Serum urate level revealed that 16(51.6%) and 15 (48.4%) of the patients were hyperuricaemic at the end of the first and second months of anti-tuberculosis therapy There was no significant difference in the mean serum creatinine level of the control group 96 ^mol/L when compared with both thepre-treat value 89fimol/L (P> 0.25) as well as the value at the end of the sixth month of treatment 91 jimo!/ L (P> 0.40). However, there was a statistically significant difference in the mean creatinine clearance of the control group 102m!/min/1.73m2 when compared with the patient's mean pre-treatment value (89 ml/min/l .73m2) P< 0.05. Also the mean creatinine clearance increased to (103 ml/min/ 1.73m ) by the end of the 6th month of treatment, a value ,s statistically significant when compared with the pretreatment value of (89 ml/min/l .73m-) P< 0.05. We submit as follows; that pulmonary tuberculosis as a disease with significam impairment of renal function; despite the associ1 e rug-induced hyperuricaemia recorded during the treatment, renal function steadily improved with the treatment of v,rnary tu^crcu'os's to the extent that comparable values ludpCftmrr W3S obtaincd at !hc cnd of treatment. We conk'lth t CrC °rC ^at ^ruS"'n<*uccd hyperuricaemia associated , Cat™?nt Pl,'nionary tuberculosis has no detectable >vc effcct on renal function of the patienten_US
dc.description.sponsorshipCollege of Medicineen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINEen_US
dc.subjectHyperuriccaemiaen_US
dc.subjectDrug induceden_US
dc.subjectrenal function.en_US
dc.subjectTuberculosisen_US
dc.titleEffects of drug-induced hyperuricaemia on renal function in nigeria with pulmonary tuberculosisen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Adebisi et al_Effect_2000.pdfArticle11.43 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.